Proprietary capital · Public & private markets

Patient capital for opportunities others overlook.

ThirdGate invests its own capital across structures, asset classes, sectors and geographies, without the horizon constraints of traditional funds.

Our Approach →

Firm overview

ThirdGate Capital Global Management, LLC, together with its affiliated funds and companies, is a proprietary investment firm investing across capital structures, asset classes, industry sectors and geographies in public and private markets to generate superior risk-adjusted returns and create long-term value for our partners.

$2B
Total capital invested
67
Years of collective investment experience
6
Global offices

Figures as of [date]. Figures are the firm's representations and are subject to verification.

Global presence

Six offices. One investment conversation.

  • New York 17:40:50 GMT-4
  • Kenya 00:40:50 GMT+3
  • London 21:40:50 GMT+0
  • Mauritius 01:40:50 GMT+4
  • Singapore 05:40:50 GMT+8
  • Switzerland 22:40:50 GMT+1
Our offices →

Select investments

recent activity

View portfolio →
Life sciences 2026

Zelira Therapeutics / HOPE 1 SPV

Cornerstone investment via TGC Biotechnology Fund.

Representative investments only; inclusion does not imply performance.

Let's discuss what patient capital can do.

Contact ThirdGate →